About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On March 30, PhRMA sponsored The Hill’s event, “Pathways to Patient Affordability,” where PhRMA’s President and Chief Executive Officer, Stephen J. Ubl, joined author and journalist, Kathleen Koch, for a conversation about the barriers to achieving patient affordability. Ubl discussed how the predatory practices of middlemen, such as not sharing cost savings with patients, force patients to pay more at the pharmacy counter.
In addition to PhRMA’s sponsored segment, the event included a panel of industry experts, and two conversations with members of Congress. The panel featured representatives from the biopharmaceutical, pharmacy, PBM, and patient advocate industries, who each shared what they see as the path forward to achieve patient access and affordability. From opposite sides of the aisle, the two policymakers shared their concerns about PBM business practices and their impact on affordability.
When
March 30, 2023 at 11:00 AMET
Speakers:
- Stephen J. Ubl, President and Chief Executive Officer, PhRMA
- Kathleen Koch, Author and Journalist (sponsored session moderator)
- Lei Ding, Senior Vice President, Market Access & Commercial Capabilities, Astellas Pharma US
- Douglas Hoey, CEO, National Community Pharmacists Association
- Kristin Bass, Chief Policy & External Affairs Officer, Pharmaceutical Care Management Association (PCMA)
- Gary Puckrein, PhD, President & CEO, National Minority Quality Forum
- Sen. Tom Carper (D-DE), Member, Health Care Subcommittee, Finance Committee
- Rep. Buddy Carter (R-GA1), Member, Health Subcommittee, Energy & Commerce Committee
- Bob Cusack, Editor-in-Chief, The Hill (moderator)
Event
Cost and Value
Pathways to Patient Affordability
Pathways to Patient Affordability image